ISOTHIAZOLOQUINOLONES AND RELATED COMPOUNDS AS ANTI-INFECTIVE AGENTS
    5.
    发明公开
    ISOTHIAZOLOQUINOLONES AND RELATED COMPOUNDS AS ANTI-INFECTIVE AGENTS 有权
    ISOTHIAZOLOQUINOLONE及相关化合物作为抗感染剂

    公开(公告)号:EP1664062A1

    公开(公告)日:2006-06-07

    申请号:EP04780234.3

    申请日:2004-08-04

    IPC分类号: C07D513/04 A61K31/435

    CPC分类号: C07D513/04

    摘要: The invention provides compounds and salts of Formula (I) and Formula (II): which possess antimicrobial activity. The invention also provides novel synthetic intermediates useful in making compounds of Formula (I) and Formula (II). The variables A1, R2, R3, R5, R6, R7, A8 and R9 are defined herein. Certain compounds of Formula (I) and Formula (II) disclosed herein are potent and selective inhibitors of bacterial DNA synthesis and bacterial replication. The invention also provides antimicrobial compositions, including pharmaceutical compositions, containing one or more compounds of Formula (I) or Formula (II) and one or more carriers, excipients, or diluents. Such compositions may contain a compound of Formula (I) or Formula (II) as the only active agent or may contain a combination of a compound of Formula (I) or Formula (II) and one or more other active agents. The invention also provides methods for treating microbial infections in animals.

    SUBSTITUTED TARAXASTANES USEFUL FOR TREATING VIRAL INFECTIONS
    7.
    发明公开
    SUBSTITUTED TARAXASTANES USEFUL FOR TREATING VIRAL INFECTIONS 审中-公开
    取代TARAXASTANE用于治疗病毒感染

    公开(公告)号:EP1986654A2

    公开(公告)日:2008-11-05

    申请号:EP07751388.5

    申请日:2007-02-20

    IPC分类号: A61K31/56 C07J63/00 A61P31/18

    CPC分类号: C07J63/008 C07C62/32

    摘要: Substituted taraxastanes useful for treating viral infections, are provided herein. Thus, in a first aspect, the invention provides compounds of Formula I and the pharmaceutically acceptable salts thereof, wherein the variables Ri, R2, and X are defined herein. The compounds described herein are thought to act by inhibiting retroviral maturation, including maturation of encapsulated retroviruses viruses, such as the HIV viruses, HIV-I and HIV-2. Pharmaceutical compositions comprising such compounds of Formula I are included herein. Methods of using such compounds to treat human patients infected with an HIV virus and reducing the mortality of AIDS are also provided herein.